PL3154542T3 - Sposoby i kompozycje przeciwdziałające nastrojowi depresyjnemu - Google Patents

Sposoby i kompozycje przeciwdziałające nastrojowi depresyjnemu

Info

Publication number
PL3154542T3
PL3154542T3 PL15806621T PL15806621T PL3154542T3 PL 3154542 T3 PL3154542 T3 PL 3154542T3 PL 15806621 T PL15806621 T PL 15806621T PL 15806621 T PL15806621 T PL 15806621T PL 3154542 T3 PL3154542 T3 PL 3154542T3
Authority
PL
Poland
Prior art keywords
counteracting
ways
compositions
depressive mood
depressive
Prior art date
Application number
PL15806621T
Other languages
English (en)
Inventor
Jeffrey H. MEYER
Original Assignee
Centre For Addiction And Mental Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre For Addiction And Mental Health filed Critical Centre For Addiction And Mental Health
Publication of PL3154542T3 publication Critical patent/PL3154542T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL15806621T 2014-06-13 2015-06-12 Sposoby i kompozycje przeciwdziałające nastrojowi depresyjnemu PL3154542T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462011888P 2014-06-13 2014-06-13
PCT/CA2015/050548 WO2015188280A1 (en) 2014-06-13 2015-06-12 Methods and compositions addressing depressed mood
EP15806621.7A EP3154542B1 (en) 2014-06-13 2015-06-12 Methods and compositions addressing depressed mood

Publications (1)

Publication Number Publication Date
PL3154542T3 true PL3154542T3 (pl) 2021-11-08

Family

ID=54832667

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15806621T PL3154542T3 (pl) 2014-06-13 2015-06-12 Sposoby i kompozycje przeciwdziałające nastrojowi depresyjnemu

Country Status (10)

Country Link
US (1) US10034852B2 (pl)
EP (2) EP3154542B1 (pl)
CA (2) CA3211086A1 (pl)
DK (1) DK3154542T3 (pl)
ES (1) ES2883858T3 (pl)
HU (1) HUE055700T2 (pl)
LT (1) LT3154542T (pl)
PL (1) PL3154542T3 (pl)
PT (1) PT3154542T (pl)
WO (1) WO2015188280A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10478467B2 (en) 2014-06-13 2019-11-19 Centre For Addiction And Mental Health Methods and compositions addressing depressed mood
US11684647B2 (en) * 2014-06-13 2023-06-27 Centre For Addiction And Mental Health Methods, compositions, and kits addressing depressed mood
US11213561B2 (en) * 2017-06-09 2022-01-04 Rox IP Pty Ltd. Herbal methods for the improvement of sleep, social interaction, concern or worry
EP4558172A1 (en) * 2022-07-19 2025-05-28 Centre For Addiction And Mental Health Amino acid oral liquid composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377595A (en) 1979-08-13 1983-03-22 Massachusetts Institute Of Technology Process for reducing depression
US6083526A (en) 1997-05-22 2000-07-04 Gorbach; Sherwood L. Use of isoflavonoids in the treatment or prevention of postpartum depression
US20070286909A1 (en) 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions

Also Published As

Publication number Publication date
CA2951955A1 (en) 2015-12-17
CA2951955C (en) 2023-10-17
WO2015188280A1 (en) 2015-12-17
CA3211086A1 (en) 2015-12-17
LT3154542T (lt) 2021-10-25
EP3922245A1 (en) 2021-12-15
DK3154542T3 (da) 2021-09-06
US20170157085A1 (en) 2017-06-08
EP3154542B1 (en) 2021-07-21
ES2883858T3 (es) 2021-12-09
HUE055700T2 (hu) 2021-12-28
US10034852B2 (en) 2018-07-31
PT3154542T (pt) 2021-09-08
EP3154542A1 (en) 2017-04-19
EP3154542A4 (en) 2018-01-10

Similar Documents

Publication Publication Date Title
NL301227I2 (nl) Tabelecleucel
EP3370782A4 (en) SCENT SUPPLY
EP3205103C0 (en) INTER AND INTRA UNIFICATION BLOCK COPY
DK3235465T3 (da) Implantat
HUE049233T2 (hu) C9ORF72-expresszió módosítására szolgáló készítmények
DK3040326T3 (da) Haloolefin-baseret sammensætning
DK3171891T3 (da) Fremgangsmåde
DK3542812T3 (da) Glycopeptidsammensætninger
HUE055877T2 (hu) Ataxin-2 expresszióját módosító készítmények
FR3024363B1 (fr) Composition thermogelifiable
DK3110442T3 (da) Modificerede meningokok-fhbp-polypeptider
DK3186242T3 (da) Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere
FI20145590A7 (fi) Muuntaja
CL2017000639A1 (es) Composición
PL3016663T3 (pl) Sterylizowana kompozycja termożelowalna
EP3236746C0 (en) COMPOSITION
PL3154542T3 (pl) Sposoby i kompozycje przeciwdziałające nastrojowi depresyjnemu
DK3200827T3 (da) Sammensætninger
FR3022772B1 (fr) Composition parfumante amelioree
FR3024647B1 (fr) Transat de puericulture
DK3217964T3 (da) Sammensætning
EP3256174C0 (de) Sterilisator
FR3019552B1 (fr) Composition filmogene
DK3218439T3 (da) Belægningssammensætninger
EP3171776C0 (de) Abbildungsanordnung